Elevated nuchal translucency, is it time to discuss the cut off?
International Journal of Gynecology & Obstetrics · 2023
DOI: 10.1002/ijgo.14834 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2023. Verfasst von Lucia Pasquini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine Unit, Department for Woman and Child Health, Careggi University Hospital, Florence, Italy. Hauptthemen laut MEDLINE: Abortion, Spontaneous, Chromosome Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objective
We aimed to evaluate pregnancy and postnatal outcomes of fetuses with NT between 95th and 99th percentile at first trimester and whether they could benefit from further investigations rather that routine scans.
Methods
Multicenter retrospective observational study which involved all cases with NT between 95th and 99th percentile from January 2015 to December 2020. Unfavorable outcome was considered as: miscarriage or intrauterine fetal death (IUFD), chromosomal abnormality/genetic syndrome, major malformation or neurodevelopmental delay. Study population outcomes were compared with general population.
Results
The rate of unfavorable outcome was 25.44% (167 out of 667). We reported: 6 (0.90%) second trimester miscarriage or IUFD, 90 (13.49%) chromosomal abnormalities/genetic syndromes, 57 (8.55%) major malformations, 13 (1.95%) cases of neurodevelopmental delay. The incidence of chromosomal abnormalities/genetic syndromes and major malformations were significantly higher (OR 6.99 (IC 95% 4.33–11.28), P < 0.001 and OR 17.77 (IC 95%7.22–43.75), P < 0.001 respectively) compared to the general population. The incidence of neurodevelopmental delay was not increased (OR of 0.64 CI 95% 0.33–1.24 P = 0.185).
Conclusions
Fetuses with NT between 95th and 99th percentile have an increased risk of pregnancy and postnatal adverse outcomes. According to our data it is reasonable to consider a lower cut of NT (NT > 95th percentile) for offering further investigations such as detailed ultrasound scan, fetal echocardiography and counseling where the option of performing fetal karyotype and CGH array should be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fetal Medicine Unit, Department for Woman and Child Health, Careggi University Hospital, Florence, Italy.
- Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.
- Division of Prenatal Diagnosis, Piero Palagi Hospital, Florence, Italy.
- Obstetrics and Gynecology, Department of Maternal and Child Health, University of Florence, Careggi University Hospital, Florence, Italy.
ORCID-Profile: Lucia Pasquini, Ilaria Ponziani, Elisa Spataro, Giulia Masini, Adalgisa Cordisco, Felice Petraglia
Zitieren
APA
Pasquini, L., Ponziani, I., Spataro, E., Masini, G., Biancareddu, E., Cordisco, A., & Petraglia, F. (2023). Elevated nuchal translucency, is it time to discuss the cut off?. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.14834
Vancouver
Pasquini L, Ponziani I, Spataro E, Masini G, Biancareddu E, Cordisco A, et al. Elevated nuchal translucency, is it time to discuss the cut off?. International Journal of Gynecology & Obstetrics. 2023. doi:10.1002/ijgo.14834
BibTeX
@article{Pasquini2023,
author = {Pasquini, Lucia and Ponziani, Ilaria and Spataro, Elisa and Masini, Giulia and Biancareddu, Eleonora and Cordisco, Adalgisa and Petraglia, Felice},
title = {Elevated nuchal translucency, is it time to discuss the cut off?},
journal = {International Journal of Gynecology & Obstetrics},
year = {2023},
doi = {10.1002/ijgo.14834}
}
EUVIMED